• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Champions Oncology Inc

+ Add to Watchlist

CSBR:US

0.6500 USD 0.0350 5.11%

As of 20:10:00 ET on 09/23/2014.

Snapshot for Champions Oncology Inc (CSBR)

Open: 0.6900 Day's Range: 0.6500 - 0.6900 Volume: 23,800
Previous Close: 0.6850 52wk Range: 0.6500 - 1.8000 1-Yr Rtn: -63.48%

Stock Chart for CSBR

No chart data available.
  • CSBR:US 0.6500
  • 1D
  • 1M
  • 1Y
0.6850
Interactive CSBR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CSBR

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.1280
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 43.48
Shares Outstanding (M) 66.89
30 Day Average Volume 6,069
Price/Book (mrq) 9.6887
Price/Sale (ttm) 4.3407
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 12/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CSBR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CSBR

Champions Oncology, Inc. develops oncology drugs. The Company implants primary human tumors in immune-deficient mice and propagates the resulting engraftments such that the biological characteristics of the original human tumor are preserved. Champions Oncology then tests oncology drugs on the engraftments.

Joel AckermanCEO/SecretaryRonnie MorrisPresident
Angela M DaviesChief Medical OfficerJames J McGorryExec VP/Gen Mgr:Translational Oncology
More Company Profile & Key Executives for CSBR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil